Cyclo Therapeutics, Inc. announced a private placement to issue 2,514,970 shares at an issue price of $0.835 per share for the gross proceeds of $2,099,999.95 on May 2, 2023. The transaction included participation from new investor Rafael Holdings, Inc. The company also issued warrants to purchase an additional 2,514,970 shares of common stock at an exercise price of $0.71 and have a term of seven years. The securities described above were offered by Cyclo Therapeutics in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the Act) and/or Regulation D promulgated thereunder, and such securities have not been registered under the Act or applicable state securities laws.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.72 USD | +0.88% | -1.15% | -6.01% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1.72 USD | +0.88% | -1.15% | 42.29M | ||
1.47 USD | +16.67% | +16.67% | 42.21M | ||
1st Jan change | Capi. | |
---|---|---|
-6.01% | 42.29M | |
+39.94% | 28.07B | |
-13.85% | 26.92B | |
+22.78% | 26.28B | |
+1.61% | 26.06B | |
+49.67% | 22.69B | |
+5.96% | 20.3B | |
+3.66% | 19.59B | |
+30.95% | 16.31B | |
-6.26% | 15.21B |
- Stock Market
- Equities
- RFL Stock
- News Rafael Holdings, Inc.
- Cyclo Therapeutics, Inc. announced that it has received $2.1 million in funding from Rafael Holdings, Inc.